Candesartan for cardiovascular prevention in Japanese hypertensive patients with coronary heart disease

被引：0
|
作者：
Staessen, Jan A. [1 ,2 ]
Richart, Tom [2 ]
Birkenhaeger, Willem H. [3 ]
机构：
[1] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands
[2] Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis, Louvain, Belgium
[3] Erasmus Univ, Rotterdam, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷 / 10期
关键词：
BLOOD-PRESSURE REDUCTION; HIGH-RISK; EVENTS; METAANALYSIS; TELMISARTAN; INTERVENTION; MORTALITY; TRIALS; DRUGS;
D O I：
10.1093/eurheartj/ehp155
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1164 / 1166
页数：3
相关论文
共 50 条
  • [1] Effects of Candesartan on Cardiovascular Outcomes in Japanese Hypertensive Patients
    Hiromichi Suzuki
    Yoshihiko Kanno
    Hypertension Research, 2005, 28 : 307 - 314
  • [2] Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients
    Suzuki, H
    Kanno, Y
    HYPERTENSION RESEARCH, 2005, 28 (04) : 307 - 314
  • [3] SECONDARY PREVENTION IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE
    Zivkovic, R.
    Lambic, L. J. Suric
    Zdravkovic, M.
    JOURNAL OF HYPERTENSION, 2015, 33 : E131 - E131
  • [4] SECONDARY PREVENTION IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE
    Zhuravlyova, L.
    Filonenko, M.
    JOURNAL OF HYPERTENSION, 2015, 33 : E131 - E132
  • [5] Effect of Amlodipine plus Candesartan on Cardiovascular Events in Hypertensive Patients With Coronary Artery Disease (from The Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Study)
    Yamatzuchi, Junichi
    Hagiwara, Nobuhisa
    Ociawa, Hiroshi
    Koyanagi, Ryo
    Kasanuki, Hiroshi
    Takagi, Atsushi
    Mori, Fumiaki
    Nagashima, Michitaka
    Yagi, Masahiro
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (06): : 819 - 824
  • [6] Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients (vol 28, pg 307, 2005)
    Suzuki, H
    Kanno, Y
    HYPERTENSION RESEARCH, 2005, 28 (06) : 553 - 553
  • [7] Statins are effective for prevention of cardiovascular events in patients without coronary heart disease
    McAlister, Finlay A.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (08)
  • [8] Cardiovascular prevention in coronary heart disease patients: guidelines implementation in clinical practice
    Ogawa Indio do Brasil, Clarisse Kaoru
    Avezum Junior, Alvaro
    Uint, Luciana
    Del Monaco, Maria Isabel
    de Barros, Valeria Mozetic
    Rachid Campos, Soraia Youssef
    Sousa, Amanda M. R.
    REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2013, 28 (02): : 238 - 247
  • [9] Global risk, statin eligibility and secondary coronary heart disease prevention in hypertensive patients
    Pedrinelli, R
    Omo, GD
    Buda, S
    Esposti, ED
    Mariani, M
    JOURNAL OF HYPERTENSION, 2003, 21 : S281 - S282
  • [10] Influence of Coronary Risk Factors on Coronary Events in Japanese High-Risk Hypertensive Patients - Primary and Secondary Prevention of Ischemic Heart Disease in a Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
    Ueshima, Kenji
    Oba, Koji
    Yasuno, Shinji
    Fujimoto, Akira
    Tanaka, Shiro
    Ogihara, Toshio
    Saruta, Takao
    Nakao, Kazuwa
    CIRCULATION JOURNAL, 2011, 75 (10) : 2411 - 2416
12345